Sym015 (Anti-MET) in Patients With Advanced Solid Tumor Malignancies

Clinical trial NCT02648724 · COMPLETED

Trial details

NCT number: NCT02648724
Sponsor: Symphogen A/S
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Oncology MET Gene Amplification NSCLC MET Gene Mutation Non Small Cell Lung Cancer

Start date: 2016-03-01
Primary completion: 2020-12-01
Enrollment: 57

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.